Skip to content

Netherlands logo

Main menu
    • About us
    • Our focus
    • Our products
    • Business development
    • Our leaders
    • Our culture
    • Policies & positions
    • Environmental, social & governance
    • Diversity, equity, inclusion & belonging
    • News
    • Media
  • Join our team

Contact Us

Back
Change Language
  • Nederlands
Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Life-size mural at Organon Oss is finished!

Save Print

June 28, 2021 3:26 am EDT

OSS – Two months ago, we proudly announced that drug company MSD had taken the initiative for a special ode to women’s health. From three designs, the people from Oss convincingly chose RoosArt’s painting, which is entitled ‘The Pride of Oss’: an ode to women’s health, history and innovation. A lot has happened since then. Rosalie de Graaf will put the finishing touches to the enormous mural on Friday 2 July. The Oss manufacturing site has now been split off from MSD: on June 3 the name Organon returned and since then the name Organon has been displayed again on a number of the company buildings in Oss. After the mural has been completed, the name will also quickly return on the blue wall: a well-known name for a new company.

Are you curious how RoosArt made the beautiful artwork? Then watch the ‘making of’ video.

The characteristic, ribbed, blue wall was placed against the factory wall of the former Organon in the early seventies. The wall needs to be replaced in a few years, but has become a household name in Oss and surroundings. The blue wall symbolizes the many innovations that have been made in Oss in the field of women’s health. In the run-up to the split MSD-Organon, MSD invited three artists to make a move for the mural and presented the designs to the Ossetians.

Executive ‘mural artist’ RoosArt talks about her design: “My design is based on nature, where medicine originates. The tree symbolizes the basis of the company, which deals with different specializations, different branches. The three people in the design symbolize research, development and production. The painting gives a look inside the factory and shows the people with the right protective clothing. The bees in the design refer to the flowers and the bees. In the early 60s, a revolution started here in Oss thanks to the introduction of the contraceptive pill and the company is still working on solutions for women’s health in an innovative way.”

In response to the choice for ‘The Pride of Oss’, Wenny Raaijmakers, plant manager Organon Oss, says: “The wall has become a real icon over the years and belongs to the city, according to the inhabitants .” Generations of them have worked at the company, which has been on that spot since 1923. “And the people in Oss are proud of that. We are therefore pleased that three thousand inhabitants have made their voices heard.”

What can we help you find?

Search for:
Netherlands logo
  • Forward-Looking Statement
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept